Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Irving › NPI 1083059505
Physician

Jacob Pediatrics PLLC

Jacob Pediatrics PLLC was paid $2.06M by Medicaid between Jan 2020 and Nov 2024, across 62 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.

33Billing provider infoJACOB PEDIATRICS PLLC
IRVING, TX 75061
33aNPI1083059505assigned 05/10/2013
33bProvider typePediatrics Physician
28Total paid$2.06M
24GClaims96,060
24DCodes billed62
24AFirst – last monthJan 2020 – Nov 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#242 of 1,136
Median peer was paid$329K
This provider vs. median6.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20204,067$82K
202122,073$428K
202224,318$539K
202326,828$585K
2024incomplete18,774$423K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 28% 12,427 11,099 $572K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 12% 3,644 3,507 $253K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 12% 3,285 3,184 $245K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 9.9% 2,558 2,502 $204K
90460 Immunization administration through 18 years of age via any route, first or only component 8.6% 16,089 7,103 $177K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7.8% 5,019 4,760 $160K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 5.2% 1,463 1,409 $107K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 5.1% 1,192 1,175 $105K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2.3% 6,336 4,957 $47K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.7% 2,688 1,299 $36K
92587 1.6% 4,767 4,661 $32K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.2% 1,621 1,566 $24K
50 more codes
90461 <1% 5,994 $14K
87807 <1% 1,183 $13K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 937 $11K
83655 <1% 1,012 $10K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 245 $9K
99204 Doctor's office visit, new patient (more involved) <1% 104 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 568 $8K
0001A <1% 174 $5K
99203 Doctor's office visit, new patient (routine) <1% 82 $4K
0002A <1% 69 $2K
99050 <1% 127 $2K
94664 <1% 137 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 24 $1K
99383 <1% 14 $1K
99382 <1% 12 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 129 $880.36
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 409 $673.88
87634 <1% 15 $589.70
88738 <1% 243 $518.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 22 $458.50
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 910 $180.24
90670 <1% 1,431 $165.33
96127 <1% 326 $66.50
99188 <1% 13 $63.00
97170 <1% 12 $50.00
81003 <1% 17 $32.13
36415 Collection of venous blood by venipuncture <1% 1,102 $17.53
90677 <1% 486 $12.33
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 299 $11.44
99173 <1% 5,330 $8.75
90686 <1% 3,292 $6.02
90621 <1% 874 $0.53
90651 <1% 820 $0.30
91300 <1% 273 $0.25
90734 <1% 314 $0.18
90656 <1% 352 $0.03
90648 <1% 1,330 $0.01
90710 0% 438 $0.00
90700 0% 327 $0.00
90633 0% 1,179 $0.00
90707 0% 273 $0.00
90715 0% 57 $0.00
90680 0% 883 $0.00
90723 0% 559 $0.00
36416 0% 1,669 $0.00
90716 0% 299 $0.00
90696 0% 275 $0.00
90698 0% 233 $0.00
90744 0% 44 $0.00
90620 0% 54 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJACOB-PARAYIL, ANITA (PRESIDENT)